Beijing Beilu Pharmaceutical Co.,Ltd.’s Net Profit Dropped 68.6% in First Half of 2022

Beijing Beilu Pharmaceutical Co.,Ltd. (北京北陆药业股份有限公司) (300016.SZ) reported a net profit of 34.3 million yuan in the first half of 2022, down 68.6% year-on-year.

Meanwhile, the company posted 351.3 million yuan in revenue, down 34.4% year-on-year.

At the end of the reporting period, it had 3 billion yuan in total assets and 877 million yuan in total liabilities, with a liability-to-asset ratio of 29.6%.